ASP2957
2957-CL-0101
Phase 2 small_molecule active
Quick answer
ASP2957 for X-linked myotubular myopathy is a Phase 2 program (small_molecule) at Astellas Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Astellas Pharma GmbH
- Indication
- X-linked myotubular myopathy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active